Johnson & Johnson Reports Q1 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Johnson & Johnson (JNJ) PT Raised to $205 at Credit Suisse
April 20, 2022 6:51 AM EDTCredit Suisse analyst Matt Miksic raised the price target on Johnson & Johnson (NYSE: JNJ) to $205.00 (from $200.00) while maintaining a Outperform rating.
... MoreJohnson & Johnson (JNJ) PT Raised to $196 at Raymond James
April 20, 2022 5:56 AM EDTRaymond James analyst Jayson Bedford raised the price target on Johnson & Johnson (NYSE: JNJ) to $196.00 (from $195.00) while maintaining a Outperform rating following results.
The analyst commented, "1Q results were mixed and the downward guidance revision, although not operational, still causes us to... More
Johnson & Johnson (JNJ) PT Raised to $210 at Citi
April 19, 2022 3:11 PM EDTCiti analyst Joanna Wuensch raised the price target on Johnson & Johnson (NYSE: JNJ) to $210.00 (from $203.00) while maintaining a Buy rating following earnings.
... MoreJohnson & Johnson (JNJ) Tops Q1 EPS by 6c, Updates FY Guidance
April 19, 2022 6:28 AM EDTJohnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.67, $0.06 better than the analyst estimate of $2.61. Revenue for the quarter came in at $23.4 billion versus the consensus estimate of $23.67 billion.
GUIDANCE:
Johnson & Johnson sees 2022 EPS of $10.15-$10.35, versus the consensus of $10.52. Johnson & Johnson... More
